The West Coast Consortium for Technology & Innovation in Pediatrics (CTIP) is an FDA funded MedTech accelerator supporting pediatric device innovators from concept to commercialization. As a CTIP portfolio members, Alerje is connected to a national network of clinical, scientific, regulatory, and business experts and eligible for services which can include:

  • Regulatory consulting

  • Reimbursement strategy

  • Manufacturing

  • Sales and Distribution Plan

  • Clinical Validation Plan

Learn more about Alerje’s product here:

Pro Basketball League teams up with Global Sports Analytics for in-depth analytics

Exciting news for Solidea's portfolio company, Global Sports Analytics!   

From EuroMillions:

"The Pro Basketball League has concluded a partnership with American company, Global Sports Analytics, as official analytics provider.

Global Sports Analytics (GSA) is a diversified technology platform that provides products and services to basketball teams, players and fans worldwide. For The Pro Basketball League, GSA has developed a proprietary analytic-platform, the EDGE, with a view of professionalizing the use of statistics in the analysis of games and players alike. 

Wim Van de Keere, general manager Pro Basketball League: "In-depth statistic analysis will become an ever more important part of basketball in Europe. It has become almost mainstream in today's NBA and NCAA. This partnership will allow our teams to set up partnerships with GSA at very competitive prices and in doing so will be able to use GSA's elaborate platform to better prepare for and analyze games."

Brandon Smith, CEO & Founder: Our group is very excited about the opportunity to support the growth of basketball in Belgium. We believe in the vision of league leadership, and look forward to providing insights for coaches, players, and fans. "

Read more here.

Solidea Co-Founder Eric Baum Joins Board of ChemioCare

July 30, 2018 NEW YORK – ChemioCare USA Inc. (“ChemioCare” or the “Company”), a biotech company focused on transforming chemotherapy induced nausea and vomiting (CINV) outcomes through transdermal patch technology, today announced a strengthening of its Board and Management team. Andy Rensink joins the Company as Chief Manufacturing Officer, Hemal Shah joins as Health Economics and Outcomes Advisor, and Eric Baum joins the Company’s Board of Directors.

“The strength and depth of our pipeline and rapid development pace are being made possible by the addition of best in class support. Andy Rensink will lead our transition from the preclinical setting into Manufacturing, and Hemal Shah is adding incredible insights into the value our products will create by addressing the significant unmet medical need in the CINV setting" said Pedro Lichtinger, Chairman and CEO. “Our Board is also strengthened by the addition of Eric Baum who has rich experience financing and advancing emerging Companies; with his addition we now have three independent directors an important step in positioning the company for a successful IPO.”

Read more here


Merlin (, the global digital rights agency for the world’s independent label sector, has partnered with Dubset.   This agreement brings the largest catalog of music in the world into the Dubset platform adding over 20 million tracks to our licensed pool from deeply respected music brands such as Armada Music, Beggars Group, Domino, Entertainment One, Epitaph/Anti, Hopeless Records, Kobalt Music Recordings, Mad Decent, Naxos, [PIAS], Secretly Group, Sub Pop and Warp.

Read more about the partnership on Billboard here:


Solidea's newest addition to its portfolio, Alerje achieved success at this year's Accelerate MI competition.    Not only was Alerje selected as a semi-finalist, but excelled past the highly competitive pool of companies as a finalist and ultimately achieved 3rd place in the overall competition winning $65,000 in investment capital and other prizes!  

Congratulations to the Alerje team and we are excited and proud to support them in our portfolio!

Read more on this year's competition here: